News and Comments

BIOTECHNOLOGY PROMISES A HUGE GROWTH

  Wednesday, December 21, 2011

EXELIXIS’ (EXEL) advanced PI3K-delta research and development preclinical program attracted Merck, known as MSD outside of the United States and Canada. “PI3K-delta is therapeutic target that academic researchers and the drug industry are racing to develop therapeutic antagonists for both inflammatory diseases and cancer. To get to Exelixis program, Merck agreed to pay $12 million in upfront payment in addition to potential milestone payments for multiple indications of up to $239 million and royalties on net-sales of products that would emerge from the agreement. Merck will also pay Exelixis royalties on any compounds that would emerge from Exelixis’ PI3K-delta program or from certain compounds that arise from Merck’s internal discovery efforts targeting PI3K-delta during a certain period. More...


Recent Postings


Archive


Tags

CompuGen (CGEN) ImmunoGen (IMGN) Benlysta (belimumab) SUNESIS PHARMACEUTICALS (SNSS) Intrexon (XON) SERES THERAPEUTICS (MCRB) Prosensa (RNA) Abbott Laboratories (ABT) VANDA (VNDA) Tysabri AERIE PHARMACEUTICALS Merck (MRK) IDERA (IDRA) Dynavax (DVAX) Micromet (MITI) ACADIA (ACAD) Seattle Genetics (SGEN) Multiple Myeloma Sarepta (SRPT) Mirati Therapeutics (MRTX) Agenus (AGEN) JUNO (JUNO) KITE (KITE) Cytokinetics (CYTK) Onyx (ONXX) Theravance Bio Pharma (TBPH) Human Longevity (HLI) Alnylam (ALNY) Anacor (ANAC) Valeant Pharmaceuticals International (VRX) Sangamo (SGMO) Elan (ELN) Prolor Biotech (PBTH) Zerenex Biogen Idec (BIIB) Genentech Idenix (IDIX) ARCA (ABIO) Biocryst (BCRX) Human Genome Sciences (HGSI) ZALTRAP™ Aimmune Therapeutics (AIMT) Intermune (ITMN) Rapamune HALOZYME (HALO) NEKTAR (NKTR)) Auspex (ASPX) Sequenom (SQNM) Roche (ROCHE) Bristol-Myers Squibb (BMY) Exelixis (EXEL) Herceptin Intercept (ICPT) Agenus (AGEN Amgen (AMGN) Ariad (ARIA) NANTKWEST (NK) Regeneron (REGN) Gilead (GILD) Roche (RHHBY) Vitae Pharmaceuticals (VTAE) Ionis (IONS) Dendreon (DNDN) Pluristem (PSTI) Array Pharmaceuticals (ARRY) Telaprevir Xoma (XOMA) C4 Therapeutics Incyte (INCY) Inovio (INO) SYNTA (SNTA) galapagos (GLPG) ISIS (ISIS) Trastuzumab-DM1 Velcade (bortezomib) ABBVIE (ABBV) BIOMARIN (BMRN) TOKAI (TKAOI) Ziofpharm (ZIOP) Illumina (ILMN) Revlimid (lenolidamide) ADVENTRIX (ANX) OSI (OSIP) KERYX (KERX) Alder Biopharmaceuticals (ALDR) Endometrial Cancer Sanofi (SNY) GUARDIAN HEALTH Sanofi-Aventis (SAN) GlaxoSmithKline (GSK) Ridaforolimus Vertex (VRTX) Jazz Pharmaceuticals (JAZZ) Anadys (ANDS) REGULUS (RGLS) Galena (GALE) Sanofi (SNA) Theravance (THRX)